These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 36901826)
1. Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease. Vrabec R; Blunden G; Cahlíková L Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901826 [TBL] [Abstract][Full Text] [Related]
2. Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease. Cahlíková L; Vrabec R; Pidaný F; Peřinová R; Maafi N; Mamun AA; Ritomská A; Wijaya V; Blunden G Molecules; 2021 Aug; 26(17):. PubMed ID: 34500673 [TBL] [Abstract][Full Text] [Related]
3. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491 [TBL] [Abstract][Full Text] [Related]
5. Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights. Rezaul Islam M; Akash S; Murshedul Islam M; Sarkar N; Kumer A; Chakraborty S; Dhama K; Ahmed Al-Shaeri M; Anwar Y; Wilairatana P; Rauf A; Halawani IF; Alzahrani FM; Khan H Brain Res; 2024 Jul; 1834():148886. PubMed ID: 38582413 [TBL] [Abstract][Full Text] [Related]
6. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target. Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716 [TBL] [Abstract][Full Text] [Related]
7. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning. Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530 [TBL] [Abstract][Full Text] [Related]
8. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Musiał A; Bajda M; Malawska B Curr Med Chem; 2007; 14(25):2654-79. PubMed ID: 17979717 [TBL] [Abstract][Full Text] [Related]
9. Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity. Pagliosa LB; Monteiro SC; Silva KB; de Andrade JP; Dutilh J; Bastida J; Cammarota M; Zuanazzi JA Phytomedicine; 2010 Jul; 17(8-9):698-701. PubMed ID: 19969445 [TBL] [Abstract][Full Text] [Related]
10. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease. Konrath EL; Passos Cdos S; Klein LC; Henriques AT J Pharm Pharmacol; 2013 Dec; 65(12):1701-25. PubMed ID: 24236981 [TBL] [Abstract][Full Text] [Related]
11. Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study. Cortes N; Sierra K; Alzate F; Osorio EH; Osorio E Phytochem Anal; 2018 Mar; 29(2):217-227. PubMed ID: 29044771 [TBL] [Abstract][Full Text] [Related]
12. Exploration of the Acetylcholinesterase Inhibitory Activity of Some Alkaloids from Amaryllidaceae Family by Molecular Docking In Silico. Castillo-Ordóñez WO; Tamarozzi ER; da Silva GM; Aristizabal-Pachón AF; Sakamoto-Hojo ET; Takahashi CS; Giuliatti S Neurochem Res; 2017 Oct; 42(10):2826-2830. PubMed ID: 28497342 [TBL] [Abstract][Full Text] [Related]
13. An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production. Orhan IE; Orhan G; Gurkas E Mini Rev Med Chem; 2011 Sep; 11(10):836-42. PubMed ID: 21762104 [TBL] [Abstract][Full Text] [Related]
15. Review of the acetylcholinesterase inhibitor galanthamine. Sramek JJ; Frackiewicz EJ; Cutler NR Expert Opin Investig Drugs; 2000 Oct; 9(10):2393-402. PubMed ID: 11060814 [TBL] [Abstract][Full Text] [Related]
16. Alkaloid metabolite profiles by GC/MS and acetylcholinesterase inhibitory activities with binding-mode predictions of five Amaryllidaceae plants. Cortes N; Alvarez R; Osorio EH; Alzate F; Berkov S; Osorio E J Pharm Biomed Anal; 2015 Jan; 102():222-8. PubMed ID: 25305596 [TBL] [Abstract][Full Text] [Related]
17. Galanthamine, a natural product for the treatment of Alzheimer's disease. Marco L; do Carmo Carreiras M Recent Pat CNS Drug Discov; 2006 Jan; 1(1):105-11. PubMed ID: 18221196 [TBL] [Abstract][Full Text] [Related]
18. Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study. Maafi N; Pidaný F; Maříková J; Korábečný J; Hulcová D; Kučera T; Schmidt M; Shammari LA; Špulák M; Carmen Catapano M; Mecava M; Prchal L; Kuneš J; Janoušek J; Kohelová E; Jenčo J; Nováková L; Cahlíková L Bioorg Med Chem Lett; 2021 Nov; 51():128374. PubMed ID: 34555506 [TBL] [Abstract][Full Text] [Related]
19. Profiling of acetylcholinesterase inhibitory alkaloids from some Shawky E; El Sohafy SM; de Andrade JP; de Souza Borges W Nat Prod Res; 2021 Mar; 35(5):807-814. PubMed ID: 30990078 [TBL] [Abstract][Full Text] [Related]
20. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study. Mazumder MK; Choudhury S Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]